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The binding of 2’(or 3’).0.(2.4.6-trinitrophcnyl)adenosine 5’.triphosphatc (TNP-ATP) to isolated bovine heart cytochrome c oxidase (COX) was 
sludied by following its specific spectral change at 510 nm. The quantitative titration revealed two bindinB sites for TNP-ATP per monomer COX 
with a Kd of 1.6 /IM. 
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1, INTRODUCTION 
Mammalian cytochrome coxidase (COX) contains 3 
catalytic on mitochondrial DNA encoded subunits and 
10 nuclear coded subunits which are absent in bacterial 
COX [1,2]. The nuclear coded subunits were suggested 
to bind allosteric effecters like nucleotides, hormones 
and second messengers and to modify the rate of elec- 
tron transport and the efficiency of energy transduction 
[ 1,3]. The activity of membrane bound COX was shown 
to be influenced by ATP either acting from the cytosolic 
[4-l I] or from the matrix side [ 12,13]. When acting from 
the cytosolic side it was not possible to distinguish be- 
tween an interaction of ATP with the substrate or with 
the enzyme, because specific binding sites for ATP have 
been identified at cytochrome c [14,15], 
The allosteric effect of nucleotides was verified, how- 
ever, by the increased K,, for cytochrome c after pho- 
toaffinity labeling af bovine heart COX with S-azido- 
ATP [G], and by the opposite effects of intraliposomal 
ATP and ADP on the K,,, for cytochrome cof reconsti- 
tuted COX from bovine heart [12], which were not ob- 
tained with COX from Pumcocctrs deh$%ms [13], 
lacking the nuclear coded subunits. 
A specific photoaffinity labeling of subunits IV and 
VIII of bovine heart COX by 8-azido-[y-32P]ATP [16] 
or L3’P]ATP [lo] was described, but this could not be 
corroborated in a later study, where most subunits were 
shown to be labeled by S-azido-[y-“‘P]ATP [7]. Thus at 
present neither the number of binding sites for ATP nor 
the involved subunits in the COX complex are known. 
In the present study the binding of TNP-ATP to COX 
from bovine heart was investigated, and a stoichiometry 
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of two TNP-ATP per monomeric COX was found. 
TNP-ATP has been previously applied as a coloured 
and fluorescent derivative of ATP to demonstrate its 
specific binding to heavy meromyosin ATPase [ 171, mi- 
tochondrial ATP-synthase [1 S-201 and H”,K’-ATPase 
[2l] by its characteristic change of absorption or flue- 
rescence. 
2. MATERIALS AND METHODS 
Trinitrobenzene sulfonic acid (TNBS) was obtained fromScrva and 
ATP from Baehringcr, Scplradex LH-30 was purchased from Pharma- 
cia. All other reagents were of the highest purity grade commercially 
avuilable. 
Bovine heart COX was prepared from isolnted mitochondria s 
described before [22]. The synthesis of TNP-ATP was performed by 
pN-controlled trinitrophcnylation of 2’- or 3’-OH of ATP by TNBS 
as described by Hiratsuka and Uchidu [ 171. The reaction product was 
purifted on a Sepbadex LH-20 column and chaructcrized by infra-red 
and NMR spectra. 
Absorption tipeClrd or TNP-ATP were carried out in IO mM K- 
WEPES, pH 7.4, and 0.05% dodccylmaltoside with an Uvikon 810 
spectrophotomcter (Kontron) as absolute spectra in the presence or 
absence of COX and as difference spectra by using tandem cuvet~cs 
lo eliminate the absorpiion of the enzyme. 
3. RESULTS AND DISCUSSION 
Addition of stoichiometric amounts of isolated COX 
from bovine heart, dissolved in dodecylmaltoside, to 
TNP-ATP results in specific binding, as shown by the 
bathochromic hange of the visible spectrum (Fig:. 1). 
The maximum of the TNP-ATP spectrum at 170 nm is 
shifted to about 480 nm, after addition of COX. Similar 
spectral changes were obtained by binding of TNP-ATP 
to heavy meromyosin ATPase [I71 and to soluble beef 
heart ATPase (F,) [IS]. 
The spectral change of TNP-ATP upon binding to 
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Fig. I. Change of the visible speclrum of TNP-ATP upon binding to 
COX, The absolute spccirum of2,uM TNP-ATP in IO mM K-HEPES. 
pH 7,4. 0.05% dodccylmaltosidc (---) and the spectrum aficr addi- 
tion of 2 PM COX to the sample und reference cuvette (---- ) is 
prescntcd, 
COX was analyzed quantitatively by titration of the 
enzyme with increasing concentrations ofTNP-ATP. In 
order to exclude the absorption of COX in the same 
spectral region, we applied tandem cuvettes, as de- 
scribed in the legend to Fig . 2. The difference spectrum, 
obtained with increasing concentrations of TNP-ATP, 
as shown in Fig. 2, indicates a saturation of the spectral 
change. This saturation becomes more evident from 
Fig 3, where the increase of the absorbance at 510 nm 
and at 510 nm minus 350 nm, taken from the difference 
spectra of Fig. 2, are plotted against he concentration 
of TNP-ATP. While at 510 nm a saturation of the spec- 
tral change is found, at 510 nm minus 350 nm two 
phases of absorbance increase are obtained. Stoichiom- 
etries (i.e. mol TNP-ATP per mol COX) were estimated 
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Fig. 2. Titration oTCOX with TNP-ATP. Diffcrencc spectra of TNP- 
ATP arc shown. The measurements wcrc performed with tandem 
cuvettes, containing TNP-ATP and COX either in the Same (sample) 
or in separate compartments (refiircncc). The twocompartmcnttiofthc 
cuvettes contained 10 mM K-HEPES, pH 7.4,0.05% dodecylmalto- 
side, and one compartment ofeach cuvctte Eontaincd 1pM COX. The 
indicated amounts of TNP-ATP were added cithcr to the COX con- 
taining comportment (sample) or to the COX-frcccompartmml. Vol- 
ume changes were corrected by buffer additions. 
by extrapolation from the initial part of the titration 
curves, where it is assumed that all added substrate is 
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Fig. 3. Snluration of the spectral chan~c 01’ TNP-ATP upon binding to COX. The absolute absorbance ditlWnncc at 510 nm ( M) and the 
difference of the absorbance at 510 nm and 350 nm (m--o) are presented ai increasing concentrations or lIP-ATP. The data W!X taken from 
Fig. 2. Stoichiamctries (i.e. mol of TNP-ATP/mol of COX) were estimated by extrapolation from the initial pan Of the litration curW where it 
is assumed that all substrate is bound, to the maximal absorbance chiin6c. 
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bound, and from the second (saturation) phase, as dcne 
in a previous publication [19]. The second phase of low 
affinity binding, obtained at 510 nm minus 350 nm, can 
be explained by the spectral change of COX at 350 nm, 
due to additional unspecific binding of TNP-ATP. In 
both cases a stoichiometry of 2 mol TNP-ATP per mol 
COX is obtained. 
From Fig. 3, a Kd value of 1.6 ,uM is graphically 
determined for the binding of TNP-ATP to bovine heart 
COX. This K,, value for TNP-ATP, however, is proba- 
bly lower than the value for non-derivatized ATP. 
which is expected to be in the millimolar range, i.e. the 
matrix nucleotide concentration range, because the trin- 
itrophenyl-group will increase the affinity of ATP to the 
hydrophobic enzyme, as found previously for other en- 
zymes [17,1 VO]. 
In order to investigate how many binding sites for 
TNP-ATP exist at the outer cytosolic side of COX, we 
have titrdtcd the enzyme with TNP-ATP after reconsti- 
tution in liposomes. Under these conditions no satura- 
tion of the spectral change at 5 10 nm was obtained (not 
shown), probably due to unspecific binding of TNP- 
ATP to liposomes. 
The number of two TNP-ATP bound to solubilized 
COX from bovine heart, as found in this investigation, 
would be in accordance with the assumption of one 
binding site for ATP on the cytosolic and another one 
on the matrix side. The identity of the subunit(s) with 
which the nucleotide interacts, however, remains to be 
demonstrated. 
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